XML 26 R7.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Changes in Equity - USD ($)
shares in Millions, $ in Millions
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Net Unrealized Gains (Losses) on Investments [Member]
Foreign Currency Translation (Losses) Gains [Member]
Noncontrolling Interest
Balance at Dec. 31, 2021 $ 75,045 $ 10 $ 0 $ 77,134 $ 423 $ (5,807) $ 3,285
Balance (in shares) at Dec. 31, 2021   941          
Net earnings attributable to UnitedHealth Group common shareholders 20,120     20,120      
Net earnings attributable to nonredeemable noncontrolling interest             406
Net earnings, Including Portion Attributable to Nonredeemable Noncontrolling Interest 20,526            
Other comprehensive (loss) income (3,009)       (3,201) 192  
Issuances of common stock, and related tax effects (in shares)   7          
Issuances of common stock, and related tax effects 903 $ 0 903        
Share-based compensation 875   875        
Common share repurchases (in shares)   (14)          
Common share repurchases (7,000) $ (1) (1,892) (5,107)      
Cash dividends paid on common shares ($8.18 per share, $7.29 per share and $6.40 per share for the years ended December 31, 2024, 2023 and 2022, respectively) (5,991)     (5,991)      
Redeemable noncontrolling interests fair value and other adjustments 114   114      
Acquisition and other adjustments of nonredeemable noncontrolling interests 374           374
Distributions to nonredeemable noncontrolling interests (387)           (387)
Balance at Dec. 31, 2022 81,450 $ 9 0 86,156 (2,778) (5,615) 3,678
Balance (in shares) at Dec. 31, 2022   934          
Net earnings attributable to UnitedHealth Group common shareholders 22,381     22,381      
Net earnings attributable to nonredeemable noncontrolling interest             575
Net earnings, Including Portion Attributable to Nonredeemable Noncontrolling Interest 22,956            
Other comprehensive (loss) income 1,366       807 559  
Issuances of common stock, and related tax effects (in shares)   6          
Issuances of common stock, and related tax effects 1,231 $ 0 1,231        
Share-based compensation $ 1,027   1,027        
Common share repurchases (in shares) (16) (16)          
Common share repurchases $ (8,059) $ 0 (2,057) (6,002)      
Cash dividends paid on common shares ($8.18 per share, $7.29 per share and $6.40 per share for the years ended December 31, 2024, 2023 and 2022, respectively) (6,761)     (6,761)      
Redeemable noncontrolling interests fair value and other adjustments (201)   (201)        
Acquisition and other adjustments of nonredeemable noncontrolling interests 1,928           1,928
Distributions to nonredeemable noncontrolling interests (516)           (516)
Balance at Dec. 31, 2023 $ 94,421 $ 9 0 95,774 (1,971) (5,056) 5,665
Balance (in shares) at Dec. 31, 2023 924 924          
Net earnings attributable to UnitedHealth Group common shareholders $ 14,405     14,405      
Net earnings attributable to nonredeemable noncontrolling interest             663
Net earnings, Including Portion Attributable to Nonredeemable Noncontrolling Interest 15,068            
Other comprehensive (loss) income 3,640       (255) 3,895  
Issuances of common stock, and related tax effects (in shares)   8          
Issuances of common stock, and related tax effects 1,485 $ 0 1,485        
Share-based compensation $ 963   963        
Common share repurchases (in shares) (17) (17)          
Common share repurchases $ (9,005) $ 0 (2,395) (6,610)      
Cash dividends paid on common shares ($8.18 per share, $7.29 per share and $6.40 per share for the years ended December 31, 2024, 2023 and 2022, respectively) (7,533)     (7,533)      
Redeemable noncontrolling interests fair value and other adjustments (53)   (53)        
Acquisition and other adjustments of nonredeemable noncontrolling interests 26           26
Distributions to nonredeemable noncontrolling interests (744)           (744)
Balance at Dec. 31, 2024 $ 98,268 $ 9 $ 0 $ 96,036 $ (2,226) $ (1,161) $ 5,610
Balance (in shares) at Dec. 31, 2024 915 915